News
Amazon S3 on MSN9h
The story of Sarepta's Duchenne gene therapyThe last couple of weeks has been particularly distressing for Duchenne muscular dystrophy patients and their families. The ...
TipRanks on MSN6h
Sarepta Stock (SRPT) Rallies on FDA Nod for Broader Gene Therapy UseShares of Sarepta Therapeutics ($SRPT) jumped over 14% on Tuesday after the FDA authorized the company to restart shipments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback